Founded in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company dedicated to revolutionizing wound care through innovative hemostatic technologies. The company's core mission is to save lives by providing safe, effective, and reliable solutions to stop bleeding quickly. Cresilon's flagship product, VETIGEL, is designed for both human and veterinary use, addressing critical needs in trauma care by rapidly controlling hemorrhages.
Cresilon has garnered attention from notable investors and industry leaders for its groundbreaking work in medical technology. The company has achieved significant milestones, including FDA approvals and widespread adoption of VETIGEL in various medical settings. Cresilon's impact extends globally, setting new standards in emergency and surgical care, and significantly improving patient outcomes through its advanced hemostatic solutions.
